Observational Health Data Sciences and Informatics

User Tools

Site Tools

Trace: • implementation_international_drug_vocabulary • treatment_pathways_in_chronic_disease_12_mos • drugs_in_peds • comparison_of_combination_treatment_in_hypertension • ohdsi_fhir_wg_monthly_meeting_on_june_15_2017
research:treatment_pathways_in_cancer_12mo

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
research:treatment_pathways_in_cancer_12mo [2017/12/19 07:27] – rchenresearch:treatment_pathways_in_cancer_12mo [2017/12/19 20:15] (current) – rchen
Line 1: Line 1:
-====== Early Treatment Pathways in Patients with Cancer ======+====== Treatment Pathways in Patients with Cancer ======
  
  
Line 8: Line 8:
 **Rationale:** Despite our recent characterization of treatment pathways, there is still little known about the prevalence real-world pathways for the treatment of chronic co-morbid conditions in patients with cancer. While numerous treatment guidelines exist for chronic conditions, it is unclear whether such guidelines are appropriate or followed for cancer patients and how real-world cancer patients are treated for such diseases. Understanding these pathways will establish context around questions of drug utilization, effectiveness, and adherence in this uniquely vulnerable population, and also demonstrate the feasibility of carrying out large-scale network studies in patients with cancer. **Rationale:** Despite our recent characterization of treatment pathways, there is still little known about the prevalence real-world pathways for the treatment of chronic co-morbid conditions in patients with cancer. While numerous treatment guidelines exist for chronic conditions, it is unclear whether such guidelines are appropriate or followed for cancer patients and how real-world cancer patients are treated for such diseases. Understanding these pathways will establish context around questions of drug utilization, effectiveness, and adherence in this uniquely vulnerable population, and also demonstrate the feasibility of carrying out large-scale network studies in patients with cancer.
  
-**Project Leads:** George Hripcsak+**Project Leads:** George Hripcsak, Ray Chen, Thomas Falconer
  
 **Coordinating Institution(s):** Columbia University **Coordinating Institution(s):** Columbia University
  
-** Additional Participants:** TBD+** Additional Participants:** Janssen R&D
  
-**Full Protocol:** [[https://github.com/OHDSI/StudyProtocols/blob/master/Study%202%20-%20Treatment%20Pathways%2012mo/OHDSITreatmentPathwaysinChronicDisease12monthprotocol.docx?raw=true|Chronic Disease Treatment Pathways 12-month Protocol]]+**Full Protocol:** [[https://github.com/rchen-cumc/StudyProtocols/blob/master/TreatmentPathways-Cancer12mo/Protocol/OHDSITxPathCancer12moProtocol.docx|Treatment Pathways in Patients with Cancer 12 months Study Protocol]]
  
 **Initial Proposal Date:**  12/19/2017 **Initial Proposal Date:**  12/19/2017
Line 29: Line 29:
 **CDM:** V5 **CDM:** V5
  
-**Database Dialect:** SQL Server, Postgres, Oracle+**Database Dialect:** SQL Server, Postgres, Oracle, Redshift
  
 **Software:**  SQL, R **Software:**  SQL, R
    
 ===== Code =====  ===== Code ===== 
-[[To be released soon]]+[[https://github.com/rchen-cumc/StudyProtocols/tree/master/TreatmentPathways-Cancer12mo|Github repo]]
  
 ===== Discussion =====  ===== Discussion ===== 
-[[TBD]] +[[http://forums.ohdsi.org/t/ohdsi-study-treatment-pathways-in-patients-with-cancer/3778|Cancer Treatment Pathways Discussion Thread]] 
  
 ===== Datasets Run =====  ===== Datasets Run ===== 
research/treatment_pathways_in_cancer_12mo.1513668461.txt.gz · Last modified: by rchen
Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki